Raymond James & Associates’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-11,002
| Closed | -$126K | – | 3477 |
|
|
2017
Q4 | $126K | Buy |
11,002
+66
| +0.6% | +$756 | ﹤0.01% | 3142 |
|
|
2017
Q3 | $134K | Sell |
10,936
-406
| -4% | -$4.98K | ﹤0.01% | 3110 |
|
|
2017
Q2 | $130K | Sell |
11,342
-6,847
| -38% | -$78.5K | ﹤0.01% | 3044 |
|
|
2017
Q1 | $378K | Buy |
18,189
+1,076
| +6% | +$22.4K | ﹤0.01% | 2546 |
|
|
2016
Q4 | $356K | Buy |
17,113
+25
| +0.1% | +$520 | ﹤0.01% | 2527 |
|
|
2016
Q3 | $560K | Buy |
17,088
+2,568
| +18% | +$84.2K | ﹤0.01% | 2193 |
|
|
2016
Q2 | $363K | Buy |
14,520
+2,956
| +26% | +$73.9K | ﹤0.01% | 2290 |
|
|
2016
Q1 | $283K | Sell |
11,564
-237
| -2% | -$5.8K | ﹤0.01% | 2365 |
|
|
2015
Q4 | $390K | Buy |
11,801
+398
| +3% | +$13.2K | ﹤0.01% | 2098 |
|
|
2015
Q3 | $374K | Buy |
+11,403
| New | +$374K | ﹤0.01% | 2049 |
|